Nasdaq
BEAM
Beam Therapeutics Inc.
- Health Care
- Listed 2020
- 1 day
- +0.7%
- 1 month
- −28.1%
- 1 year
- +48.9%
$27.25 · Mkt cap $2.81B
At the 6 Aug 2026 close
Nasdaq
Beam Therapeutics Inc.
$27.25 · Mkt cap $2.81B
At the 6 Aug 2026 close
Beam Therapeutics Inc. trades under the ticker BEAM on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $2.81B. The last closing price was $27.25, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +48.9%, and −28.1% over the past month. Returns are price returns and exclude dividends.
This page exists because BEAM is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.